| |||||||||||||||||||||||||||||||||||
Parent-child relations graph | Deprecated MNXref IDs graph |
Identifier | Description |
---|---|
CHEBI:77980 chebi:77980 | aclacinomycin A (1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylammonio)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate aclacinomycin A zwitterion |
kegg.compound:C18638 keggC:C18638 kegg.glycan:G09914 keggG:G09914 | Aclacinomycin A |
seed.compound:cpd19901 seedM:cpd19901 | Aclacinomycin A aclacinomycin A aclarubicin |
kegg.drug:D02756 keggD:D02756 | Aclarubicin (USAN/INN) ACM Aclacinomycin A |
CHEBI:74353 chebi:74353 | aclacinomycin A(1+) (1S,3R,4R)-3-ethyl-3,10,12-trihydroxy-4-(methoxycarbonyl)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranoside |
CHEBI:74619 chebi:74619 | aclacinomycin A MA 144-A1 aclarubicin aclarubicina aclarubicine aclarubicinum methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate |
metacyc.compound:CPD-12960 metacycM:CPD-12960 | aclacinomycin A aclarubicin |
keggC:M_C18638 keggD:M_D02756 keggG:M_G09914 seedM:M_cpd19901 | secondary/obsolete/fantasy identifier |